The
future of pharmacy has been an
ongoing to some years. The advances in technology of all kinds, and their
impact on the profession, are a serious concern. Within the advances in
artificial intelligence and fuzzy logic and in logistics and supply we are must
be concerned for the future of pharmacy. Then development of the medical technology affects every aspect of medicine
and healthcare and an even the seemingly most remote and ivory-tower-like
institution, pharmacy, cannot escape its transformative power. The
we are show bright future of pharmacies. In the world was plunged into a new reality and it is easy to
imagine that the pharmacy professions would have simply been rendered obsolete.
The Healthcare providers are starting to realize
that the process that long existed where physicians prescribed medication
without discussing costs with patients or possible drug interactions with the
pharmacist we must evolve to improve overall population health.
Over our community pharmacy journeys, we’ve seen a level of profit from
the timely supply of medicines slowly dwindling, leaving less margin for a cross-subsidisation
of essential pharmaceutical services. Then despite this, our supply workflows
and management of the key business metrics largely remain in the same reactive
and the inefficient. Then a pharmacy
of the future will innovate to remove unnecessary time and in
the money from the supply chain through predictive supply of pre-packaged
medicines, on-demand medicine personalisation which will include 3D printing of
medicines in pharmacies, and delivery of adaptive medicine devices that respond
to individual treatment goals.
Pharmacy industry revenues are shifting from the traditional brand-name drugs to specialty drugs. Over the next four years, specialty drugs will account for 42% of the pharmacy industry’s revenues. Since more than and more of these products are being dispensed by a small number of large specialty pharmacies, community pharmacies must be strategically position themselves to handle an increasing number of these some expensive products with in unique clinical requirements as they are introduced into the market place.
Pharmacy industry revenues are shifting from the traditional brand-name drugs to specialty drugs. Over the next four years, specialty drugs will account for 42% of the pharmacy industry’s revenues. Since more than and more of these products are being dispensed by a small number of large specialty pharmacies, community pharmacies must be strategically position themselves to handle an increasing number of these some expensive products with in unique clinical requirements as they are introduced into the market place.
As pharmacists take on more responsibilities,
cost buy reductions must offset the associated increase in resource use. Then some
healthcare experts are encouraging a system that reimburses pharmacists for
these additional activities, and legislation is in the works that could make
this happen under Medicare. This resulting revenue stream would create
potential for pharmacists to bill and receive compensation for each activity
they perform. Although
this change may increase upfront costs, a recent study has shown that
integrating a pharmacist to help counsel, oversee and talk with patients
ultimately reduces overall costs for health systems and patients, lowers
readmission rates and improves overall population health. The future of
pharmacy new technology created. For more….
No comments:
Post a Comment